Evidence map›Paper›PMID 33275775›Full record

Trial reportInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2021

Effects of selenium supplementation on pregnancy outcomes and disease progression in HIV-infected pregnant women in Lagos: A randomized controlled trial.

Kehinde S Okunade, Olusola F Olowoselu, Sarah John-Olabode, Basirat O Hassan, Oluwatosin J Akinsola, Chidinma M Nwogu, Aloy O Ugwu, Olusanjo E Moses, Kabiru A Rabiu, Adegbenga Ajepe and 4 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. The Role of Selenium in Pathologies: An Updated Review.Antioxidants (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Kehinde S OkunadeDepartment of Obstetrics and Gynecology, College of Medicine, University of Lagos, Lagos, Nigeria.
Olusola F OlowoseluDepartment of Hematology and Blood Transfusion, College of Medicine, University of Lagos, Lagos, Nigeria.
Sarah John-OlabodeDepartment of Hematology and Blood Transfusion, College of Medicine, University of Lagos, Lagos, Nigeria.
Basirat O HassanAIDS Prevention Initiative in Nigeria (APIN) Clinic, Lagos University Teaching Hospital, Lagos, Nigeria.
Oluwatosin J AkinsolaDepartment of Community Health and Primary Health Care, College of Medicine, University of Lagos, Lagos, Nigeria.
Chidinma M NwoguDepartment of Obstetrics and Gynecology, Lagos University Teaching Hospital, Lagos, Nigeria.
Aloy O UgwuDepartment of Obstetrics and Gynecology, Lagos University Teaching Hospital, Lagos, Nigeria.
Olusanjo E MosesDepartment of Obstetrics and Gynecology, Lagos State University Teaching Hospital, Ikeja, Nigeria.
Kabiru A RabiuDepartment of Obstetrics and Gynecology, Lagos State University Teaching Hospital, Ikeja, Nigeria.
Adegbenga AjepeDepartment of Obstetrics and Gynecology, Lagos University Teaching Hospital, Lagos, Nigeria.
Muisi A AdenekanDepartment of Obstetrics and Gynecology, Lagos University Teaching Hospital, Lagos, Nigeria.
Adebola A AdejimiDepartment of Community Health and Primary Health Care, College of Medicine, University of Lagos, Lagos, Nigeria.
Sulaimon A AkanmuDepartment of Hematology and Blood Transfusion, College of Medicine, University of Lagos, Lagos, Nigeria.
Phyllis J KankiDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, USA.
University of Lagos · NGLagos University Teaching Hospital · NGLagos State University Teaching Hospital · NGHarvard University · US

Funding

Partnership for Global Health Research Training Program (Renewal)-Supplement for OBSSR, NCI, NCI-AIDS and NIDCDD43TW010543 · FIC · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Wafaie W Fawzi, DAVIDSON HOWES HAMER · 2017 to 2026
$12.1M
FIC NIH HHS D43 TW010543National Institute of Mental Health of the National Institutes of Health D43TW010543
6 · The paper itself

Abstract

objectiveTo examine the effects of selenium supplementation on pregnancy outcomes and disease progression among HIV-infected pregnant women in Lagos.

methodsA randomized, placebo-controlled trial conducted among HIV-positive pregnant women between September 2018 and August 2019. At enrollment, 90 women were randomly assigned into each treatment arm to receive either a daily tablet of 200 μg elemental selenium or a placebo. Relevant participants' sociodemographic and clinical data were collected at enrollment and delivery.

resultsWomen in the selenium arm had a significantly lower risk of preterm delivery (relative risk [RR] 0.32, 95% confidence interval [CI] 0.11-0.96) and a non-significant reduction in the risk of delivering term neonates with a low delivery weight (RR 0.24, 95% CI 0.05-1.19). Supplemental selenium does not increase the risk of perinatal death and adverse drug events.

conclusionThe study reported a beneficial effect of prenatal selenium supplements on the risk of preterm delivery with no further reduction in risk among HIV-infected women who used the supplements for more than 14 weeks.

trial registrationPan African Clinical Trial Registry (PACTR201809756724274).

Indexed as

Pregnancy OutcomeAdolescentAdultAntioxidantsBirth WeightDisease ProgressionDouble-Blind MethodFemaleHIV InfectionsHumansInfant, NewbornMiddle AgedNigeriaPregnancyPregnancy Complications, InfectiousPremature BirthAntioxidantsSeleniumCD4+ cell countLagosLagos University Teaching Hospitallow birth weightpreterm deliveryseleniumviral load

Identifiers

PMID33275775
PMCPMC8122028
OpenAlexW3107412503

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.